Document is current
Any future updates will be listed below
-
Authors
Jiménez-Díaz, Gabriela
Aune, Anders
Elizarrarás-Rivas, Jesús
Gierman, Lobke M.
Keitsch, Martina
Marcuzzi, Anna
Infanti, Jennifer J.
-
Funding
Funding for this research was provided by:
NTNU Norwegian University of Science and Technology
- License Information
-
More Information
Article History
Received: 7 September 2023
Accepted: 22 May 2024
First Online: 28 May 2024
Declarations
:
: The study was approved by IMSS National Scientific Research Committee (R-2022-785-061) and registered with the Norwegian Agency for Shared Services in Education and Research (599238).
: Not applicable.
: GJD and LG are employed and shareholders of Picterus AS which is currently commercializing Picterus Jaundice Pro device. AA is shareholder of Picterus AS. JJI, AM, LMG, MK and JER declare that they have no competing interests.The study objectives were explained to each participant, and they gave their written informed consent prior to their participation. The confidentiality and anonymity of the participants was guaranteed. All methods were carried out in accordance with relevant guidelines and regulations.
